TAK1 activation for cytokine synthesis and proliferation of endometriotic cells

Fuminori Taniguchi1, Tasuku Harada, Hiroko Miyakoda

  • 1Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan. tani4327@med.tottori-u.ac.jp

Insights

Tumor necrosis factor-alpha (TNFalpha) and its mediator TAK1 play a role in endometriosis. This study shows TNFalpha-induced TAK1 activation affects cell proliferation, potentially contributing to endometriosis pathogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Reproductive Medicine

Background:

  • Endometriosis is a condition causing pelvic pain and infertility.
  • Specific molecular pathways involved in endometriosis pathogenesis require further elucidation.

Purpose of the Study:

  • To investigate the role of Tumor Necrosis Factor-alpha (TNFalpha) and its downstream signaling pathways in endometriotic stromal cells (ESCs).
  • To identify key mediators, such as TAK1, involved in TNFalpha-induced cellular responses in endometriosis.

Main Methods:

  • Utilized pathway-specific cDNA arrays to analyze gene expression changes induced by TNFalpha in ESCs.
  • Employed siRNA to silence TAK1 and assessed its impact on TNFalpha-mediated signaling and cell proliferation.
  • Measured phosphorylation of key proteins (e.g., IkappaBalpha, JNK1/2, p38MAPK) and gene expression (e.g., IL-6, IL-8).

Main Results:

  • TNFalpha upregulated expressions of ICAM-3, IL-6, IL-8, TAK1, JNK2, RelA, and TLR4 in ESCs.
  • TNFalpha-induced phosphorylation of TAK1, IkappaBalpha, JNK1/2, and p38MAPK was repressed by TAK1 silencing.
  • TAK1 inhibition reduced TNFalpha-promoted cell proliferation, indicated by decreased S-phase proportion and BrdU incorporation.

Conclusions:

  • The study provides the first evidence implicating TNFalpha and its downstream mediator TAK1 in the pathogenesis of endometriosis.
  • TAK1, as a key mediator of NF-kappaB and MAPK pathways, is crucial for TNFalpha-induced cellular responses in endometriosis.
  • Targeting the TNFalpha/TAK1 pathway may offer a therapeutic strategy for endometriosis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...